Global Information
회사소개 | 문의 | 비교리스트

감염증 진단 : 세계 시장 전망(2018-2027년)

Infectious Disease Diagnostics - Global Market Outlook (2018-2027)

리서치사 Stratistics Market Research Consulting
발행일 2020년 05월 상품 코드 939198
페이지 정보 영문 131 Pages
가격
US $ 4,150 ₩ 4,757,000 PDF (Single User License)
US $ 5,250 ₩ 6,019,000 PDF (2-5 User License)
US $ 6,350 ₩ 7,280,000 PDF (Site License)
US $ 7,500 ₩ 8,598,000 PDF (Global Site License)


감염증 진단 : 세계 시장 전망(2018-2027년) Infectious Disease Diagnostics - Global Market Outlook (2018-2027)
발행일 : 2020년 05월 페이지 정보 : 영문 131 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 감염증 진단 시장은 예측 기간 중 7.1%의 CAGR로 추이하며, 2018년의 155억 3000만 달러에서 2027년에는 287억 9000만 달러 규모로 성장할 것으로 예측됩니다. 감염증 유병률의 증가, 신기술의 개발과 R&D 활동의 활발화, 감염증 억제를 위한 새로운 진단 검사의 증가 등의 요인이 이 시장의 성장을 촉진하고 있습니다. 한편, 숙련 기술자·전문가의 부족, 디바이스의 고비용성이 시장의 성장을 억제하고 있습니다.

세계의 감염증 진단 시장을 조사했으며, 시장 및 기술의 개요, 시장 성장에 대한 각종 영향요인 및 시장 기회 분석, 제품 & 서비스·기술·검사 유형·질환 유형·최종사용자·지역/주요 국가 등 각종 부문별 동향과 시장 규모의 추이와 예측, 경쟁 환경, 주요 기업의 개요 등을 정리하여 전해드립니다.

제1장 개요

제2장 서문

제3장 시장 동향 분석

  • 서론
  • 촉진요인
  • 억제요인
  • 시장 기회
  • 위협
  • 기술 분석
  • 최종사용자 분석
  • 신흥 시장
  • Covid-19의 영향

제4장 Porter의 산업 분석

제5장 세계의 감염증 진단 시장 : 제품·서비스별

  • 서론
  • 어세이·키트·시약
  • 기기
  • 소프트웨어

제6장 세계의 감염증 진단 시장 : 검사 유형별

  • 서론
  • 생검
  • 영상 검사
  • 임상 검사

제7장 세계의 감염증 진단 시장 : 기술별

  • 서론
  • 생화학적 특성 평가
  • 임상 미생물학
  • 기존 기술
  • DNA 마이크로어레이
  • DNA 시퀀스 & 차세대 시퀀스(NGS)
  • 하이브리다이제이션·마이크로어레이
  • 면역진단
  • 등온 핵산 증폭 기술(INAAT)
  • 현미경
  • 분자 기술
  • POC 감염증 진단 검사
  • 중합효소 연쇄 반응(PCR)

제8장 세계의 감염증 진단 시장 : 질환 유형별

  • 서론
  • 후천성면역결핍증후군(AIDS)
  • 세균 감염
  • 심혈관감염증
  • CT/NG(Chlamydia Trachomatis Genital Infection and Gonorrhea)
  • 코로나바이러스
  • 선열
  • 간염
  • 원내감염(HAIS)
  • 인간면역결핍바이러스(HIV)
  • 인유두종 바이러스(HPV)
  • 인플루엔자
  • 메티실린 내성 황색 포도 구균(MRSA)
  • 결핵(TB)
  • 기타

제9장 세계의 감염증 진단 시장 : 최종사용자별

  • 서론
  • 학술/조사기관
  • 외래 수술 센터
  • 혈액은행
  • 수탁 조사기관
  • 진단 클리닉
  • 홈헬스케어
  • 병원/임상 검사실
  • 양호 시설
  • 의사 오피스
  • 표준실험실

제10장 세계의 감염증 진단 시장 : 지역별

  • 서론
  • 북미
  • 유럽
  • 아시아태평양
  • 남미
  • 중동·아프리카

제11장 주요 개발

  • 계약·제휴·협업·JV
  • M&A
  • 신제품 발매
  • 확장
  • 기타 주요 전략

제12장 기업 개요

  • Abbott Diagnostic
  • Alere
  • Beckman Coulter
  • Becton, Dickinson and Company(BD)
  • bioMerieux
  • Bio-Rad Laboratories
  • Cavidi
  • Cepheid
  • Corgenix
  • Diasorin
  • Diaxonhit
  • Eiken Chemical
  • EMD Millipore
  • J.Mitra
  • Meridian Bioscience
  • Roche Diagnostic
  • Siemens Healthcare Diagnostics
  • TECHLAB
  • Thermo Fisher Scientific
  • Trinity Biotech
KSA 20.06.12

List of Tables

  • Table 1 Global Infectious Disease Diagnostics Market Outlook, By Region (2017-2027) ($MN)
  • Table 2 Global Infectious Disease Diagnostics Market Outlook, By Product & Service (2017-2027) ($MN)
  • Table 3 Global Infectious Disease Diagnostics Market Outlook, By Assays, Kits, & Reagents (2017-2027) ($MN)
  • Table 4 Global Infectious Disease Diagnostics Market Outlook, By Instruments (2017-2027) ($MN)
  • Table 5 Global Infectious Disease Diagnostics Market Outlook, By Software (2017-2027) ($MN)
  • Table 6 Global Infectious Disease Diagnostics Market Outlook, By Test Type (2017-2027) ($MN)
  • Table 7 Global Infectious Disease Diagnostics Market Outlook, By Biopsies (2017-2027) ($MN)
  • Table 8 Global Infectious Disease Diagnostics Market Outlook, By Imaging Test (2017-2027) ($MN)
  • Table 9 Global Infectious Disease Diagnostics Market Outlook, By Laboratory Tests (2017-2027) ($MN)
  • Table 10 Global Infectious Disease Diagnostics Market Outlook, By Technology (2017-2027) ($MN)
  • Table 11 Global Infectious Disease Diagnostics Market Outlook, By Biochemical Characterization (2017-2027) ($MN)
  • Table 12 Global Infectious Disease Diagnostics Market Outlook, By Clinical Microbiology (2017-2027) ($MN)
  • Table 13 Global Infectious Disease Diagnostics Market Outlook, By Conventional Techniques (2017-2027) ($MN)
  • Table 14 Global Infectious Disease Diagnostics Market Outlook, By DNA Microarray (2017-2027) ($MN)
  • Table 15 Global Infectious Disease Diagnostics Market Outlook, By DNA Sequencing & Next-Generation Sequencing (NGS) (2017-2027) ($MN)
  • Table 16 Global Infectious Disease Diagnostics Market Outlook, By Hybridization and Microarrays (2017-2027) ($MN)
  • Table 17 Global Infectious Disease Diagnostics Market Outlook, By Immunodiagnostics (2017-2027) ($MN)
  • Table 18 Global Infectious Disease Diagnostics Market Outlook, By Isothermal Nucleic Acid Amplification Technology (INAAT) (2017-2027) ($MN)
  • Table 19 Global Infectious Disease Diagnostics Market Outlook, By Microscopy (2017-2027) ($MN)
  • Table 20 Global Infectious Disease Diagnostics Market Outlook, By Molecular Techniques (2017-2027) ($MN)
  • Table 21 Global Infectious Disease Diagnostics Market Outlook, By POC infectious disease diagnostics test (2017-2027) ($MN)
  • Table 22 Global Infectious Disease Diagnostics Market Outlook, By Polymerase Chain Reaction (PCR) (2017-2027) ($MN)
  • Table 23 Global Infectious Disease Diagnostics Market Outlook, By Disease Type (2017-2027) ($MN)
  • Table 24 Global Infectious Disease Diagnostics Market Outlook, By Acquired Immunodeficiency Syndrome (AIDS) (2017-2027) ($MN)
  • Table 25 Global Infectious Disease Diagnostics Market Outlook, By Bacterial Infection (2017-2027) ($MN)
  • Table 26 Global Infectious Disease Diagnostics Market Outlook, By Cardiovascular infection (2017-2027) ($MN)
  • Table 27 Global Infectious Disease Diagnostics Market Outlook, By Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG) (2017-2027) ($MN)
  • Table 28 Global Infectious Disease Diagnostics Market Outlook, By Coronavirus (2017-2027) ($MN)
  • Table 29 Global Infectious Disease Diagnostics Market Outlook, By Glandular fever (2017-2027) ($MN)
  • Table 30 Global Infectious Disease Diagnostics Market Outlook, By Hepatitis (2017-2027) ($MN)
  • Table 31 Global Infectious Disease Diagnostics Market Outlook, By Hospital-Acquired Infections (HAIS) (2017-2027) ($MN)
  • Table 32 Global Infectious Disease Diagnostics Market Outlook, By Human Immunodeficiency Virus (HIV) (2017-2027) ($MN)
  • Table 33 Global Infectious Disease Diagnostics Market Outlook, By Human Papillomavirus (HPV) (2017-2027) ($MN)
  • Table 34 Global Infectious Disease Diagnostics Market Outlook, By Influenza (2017-2027) ($MN)
  • Table 35 Global Infectious Disease Diagnostics Market Outlook, By Methicillin-resistant Staphylococcus Aureus (MRSA) (2017-2027) ($MN)
  • Table 36 Global Infectious Disease Diagnostics Market Outlook, By Tuberculosis (TB) (2017-2027) ($MN)
  • Table 37 Global Infectious Disease Diagnostics Market Outlook, By Other Disease Types (2017-2027) ($MN)
  • Table 38 Global Infectious Disease Diagnostics Market Outlook, By End User (2017-2027) ($MN)
  • Table 39 Global Infectious Disease Diagnostics Market Outlook, By Academic/Research Institutes (2017-2027) ($MN)
  • Table 40 Global Infectious Disease Diagnostics Market Outlook, By Ambulatory Surgical Centers (2017-2027) ($MN)
  • Table 41 Global Infectious Disease Diagnostics Market Outlook, By Blood Banks (2017-2027) ($MN)
  • Table 42 Global Infectious Disease Diagnostics Market Outlook, By Contract Research Organization (2017-2027) ($MN)
  • Table 43 Global Infectious Disease Diagnostics Market Outlook, By Diagnostic Clinics (2017-2027) ($MN)
  • Table 44 Global Infectious Disease Diagnostics Market Outlook, By Home healthcare (2017-2027) ($MN)
  • Table 45 Global Infectious Disease Diagnostics Market Outlook, By Hospital/Clinical Laboratories (2017-2027) ($MN)
  • Table 46 Global Infectious Disease Diagnostics Market Outlook, By Nursing Homes (2017-2027) ($MN)
  • Table 47 Global Infectious Disease Diagnostics Market Outlook, By Physician Offices (2017-2027) ($MN)
  • Table 48 Global Infectious Disease Diagnostics Market Outlook, By Reference Laboratories (2017-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

According to Stratistics MRC, the Global Infectious Disease Diagnostics Market is accounted for $15.53 billion in 2018 and is expected to reach $28.79 billion by 2027 growing at a CAGR of 7.1% during the forecast period. Increasing prevalence of infectious diseases, growing R& D activities coupled with the development of novel technologies and rising new diagnostic tests for the control of infectious diseases are the major factors propelling the market growth. However, lack of skilled technicians/professionals and high cost of these devices is hampering the market growth.

Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Any bacteria which cause infectious disease are called pathogens. Diagnosis for the causative organism of bacterial disease is always difficult since infections show symptoms like lethargy and fever.

Based on the technology, DNA sequencing & next-generation sequencing (NGS) segment is going to have a lucrative growth during the forecast period due to factors such as development in sequencing technologies, rising awareness and taking of personalized medicine in which this technology has major applications and growing application of molecular diagnostic technologies in pharmacogenetics and point-of-care testing are expected to boost the growth of this technology in the future. By geography, North America is likely to have a huge demand owing to extremely developed healthcare system, mounting prevalence of infectious diseases, the existence of a huge number of leading national clinical laboratories, and simple accessibility to technologically advanced devices in the region.

Some of the key players profiled in the Infectious Disease Diagnostics Market are Abbott Diagnostic, Alere, Beckman Coulter , Becton, Dickinson and Company (BD), bioMerieux, Bio-Rad Laboratories, Cavidi, Cepheid, Corgenix, Diasorin, Diaxonhit , Eiken Chemical, EMD Millipore, J.Mitra, Meridian Bioscience, Roche Diagnostic , Siemens Healthcare Diagnostics, TECHLAB, Thermo Fisher Scientific and Trinity Biotech.

Product & Services Covered:

  • Assays, Kits, & Reagents
  • Instruments
  • Software

Test Types Covered:

  • Biopsies
  • Imaging Test
  • Laboratory Tests

Technologies Covered:

  • Biochemical Characterization
  • Clinical Microbiology
  • Conventional Techniques
  • DNA Microarray
  • DNA Sequencing & Next-Generation Sequencing (NGS)
  • Hybridization and Microarrays
  • Immunodiagnostics
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Microscopy
  • Molecular Techniques
  • POC infectious disease diagnostics test
  • Polymerase Chain Reaction (PCR)

Disease Types Covered:

  • Acquired Immunodeficiency Syndrome (AIDS)
  • Bacterial Infection
  • Cardiovascular infection
  • Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)
  • Coronavirus
  • Glandular fever
  • Hepatitis
  • Hospital-Acquired Infections (HAIS)
  • Human Immunodeficiency Virus (HIV)
  • Human Papillomavirus (HPV)
  • Influenza
  • Methicillin-resistant Staphylococcus Aureus (MRSA)
  • Tuberculosis (TB)
  • Other Disease Types

End Users Covered:

  • Academic/Research Institutes
  • Ambulatory Surgical Centers
  • Blood Banks
  • Contract Research Organization
  • Diagnostic Clinics
  • Home healthcare
  • Hospital/Clinical Laboratories
  • Nursing Homes
  • Physician Offices
  • Reference Laboratories

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Infectious Disease Diagnostics Market, By Product & Service

  • 5.1 Introduction
  • 5.2 Assays, Kits, & Reagents
  • 5.3 Instruments
  • 5.4 Software

6 Global Infectious Disease Diagnostics Market, By Test Type

  • 6.1 Introduction
  • 6.2 Biopsies
  • 6.3 Imaging Test
  • 6.4 Laboratory Tests

7 Global Infectious Disease Diagnostics Market, By Technology

  • 7.1 Introduction
  • 7.2 Biochemical Characterization
  • 7.3 Clinical Microbiology
  • 7.4 Conventional Techniques
  • 7.5 DNA Microarray
  • 7.6 DNA Sequencing & Next-Generation Sequencing (NGS)
  • 7.7 Hybridization and Microarrays
  • 7.8 Immunodiagnostics
  • 7.9 Isothermal Nucleic Acid Amplification Technology (INAAT)
  • 7.10 Microscopy
  • 7.11 Molecular Techniques
  • 7.12 POC infectious disease diagnostics test
  • 7.13 Polymerase Chain Reaction (PCR)

8 Global Infectious Disease Diagnostics Market, By Disease Type

  • 8.1 Introduction
  • 8.2 Acquired Immunodeficiency Syndrome (AIDS)
  • 8.3 Bacterial Infection
  • 8.4 Cardiovascular infection
  • 8.5 Chlamydia Trachomatis Genital Infection and Gonorrhea (CT/NG)
  • 8.6 Coronavirus
  • 8.7 Glandular fever
  • 8.8 Hepatitis
  • 8.9 Hospital-Acquired Infections (HAIS)
  • 8.10 Human Immunodeficiency Virus (HIV)
  • 8.11 Human Papillomavirus (HPV)
  • 8.12 Influenza
  • 8.13 Methicillin-resistant Staphylococcus Aureus (MRSA)
  • 8.14 Tuberculosis (TB)
  • 8.15 Other Disease Types

9 Global Infectious Disease Diagnostics Market, By End User

  • 9.1 Introduction
  • 9.2 Academic/Research Institutes
  • 9.3 Ambulatory Surgical Centers
  • 9.4 Blood Banks
  • 9.5 Contract Research Organization
  • 9.6 Diagnostic Clinics
  • 9.7 Home healthcare
  • 9.8 Hospital/Clinical Laboratories
  • 9.9 Nursing Homes
  • 9.10 Physician Offices
  • 9.11 Reference Laboratories

10 Global Infectious Disease Diagnostics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Abbott Diagnostic
  • 12.2 Alere
  • 12.3 Beckman Coulter
  • 12.4 Becton, Dickinson and Company (BD)
  • 12.5 bioMerieux
  • 12.6 Bio-Rad Laboratories
  • 12.7 Cavidi
  • 12.8 Cepheid
  • 12.9 Corgenix
  • 12.10 Diasorin
  • 12.11 Diaxonhit
  • 12.12 Eiken Chemical
  • 12.13 EMD Millipore
  • 12.14 J.Mitra
  • 12.15 Meridian Bioscience
  • 12.16 Roche Diagnostic
  • 12.17 Siemens Healthcare Diagnostics
  • 12.18 TECHLAB
  • 12.19 Thermo Fisher Scientific
  • 12.20 Trinity Biotech
Back to Top
전화 문의
F A Q